Frequency of injection site assessment for lipohypertrophy in children and young people with type 1 diabetes
Intended for healthcare professionals
Evidence and practice    

Frequency of injection site assessment for lipohypertrophy in children and young people with type 1 diabetes

Alice McCann Nurse specialist, paediatric diabetes, Croydon University Hospital, Croydon, England

Why you should read this article
  • To enhance your knowledge about the risk to children and young people of developing lipohypertrophy due to daily insulin injections

  • To understand why national recommendations on assessing injection sites and checking for lipohypertrophy are not being followed

  • To raise awareness of the importance of assessment skills to minimise the risk to patients

Children and young people with diabetes are at high risk of developing lipohypertrophy (LH) as a result of daily injections of insulin. LH is characterised by dense nodules that are palpable beneath the skin’s surface. A retrospective audit investigated the frequency of injection site assessment in children and young people attending a diabetes clinic over one year. The audit was conducted using the medical records of 76 eligible patients with type 1 diabetes, all treated with multiple daily injections or continuous subcutaneous insulin infusions for a minimum of six months from the audit start date.

None of the participants had their injection sites assessed at every clinic visit. Just under one third (n=23, 30%) received at least one injection site assessment within the audit year. Of these, 11 had LH detected. HbA1c and average blood glucose levels were higher in those with LH, which was deemed significant. There was a slight increase in glucose variation in those with LH compared with those without LH. However, this result was not statistically significant. The frequency of injection site assessment is low in children and young people but the prevalence of LH is high. This means it is essential to improve healthcare professionals’ injection technique education and assessment skills to minimise the risk of patients developing LH.

Nursing Children and Young People. doi: 10.7748/ncyp.2019.e1203

Peer review

This article has been subject to open peer review and has been checked for plagiarism using automated software

Correspondence

alice.mccann@nhs.uk

Conflict of interest

None declared

McCann A (2019) Frequency of injection site assessment for lipohypertrophy in children and young people with type 1 diabetes. Nursing Children and Young People. doi: 10.7748/ncyp.2019.e1203

Published online: 31 October 2019

Your organisation does not have access to this article
Recommend to your librarian
RCNi-Plus
Already have access? Log in

OR

3-month trial offer for �5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more